Matches in Nanopublications for { ?s ?p "[Carriers of the susceptible MPO and CAT genotypes were at elevated risk (OR 2.1 and 95% CI 0.7-6.2 for MPO; OR 1.9 and 95% CI 0.8-4.7 for CAT) of hyperkeratosis after adjustment for arsenic exposure and other covariates.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- NP516456.RA_BlDzhxL5sz2mSiSFgHumK0FmKt9TqriAO-aO4UWH-s130_assertion description "[Carriers of the susceptible MPO and CAT genotypes were at elevated risk (OR 2.1 and 95% CI 0.7-6.2 for MPO; OR 1.9 and 95% CI 0.8-4.7 for CAT) of hyperkeratosis after adjustment for arsenic exposure and other covariates.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP516456.RA_BlDzhxL5sz2mSiSFgHumK0FmKt9TqriAO-aO4UWH-s130_provenance.
- NP630117.RAzJoLB1-evP1_ZQs0s_YVY2He9GjFC1fLzBvb8yItPyk130_assertion description "[Carriers of the susceptible MPO and CAT genotypes were at elevated risk (OR 2.1 and 95% CI 0.7-6.2 for MPO; OR 1.9 and 95% CI 0.8-4.7 for CAT) of hyperkeratosis after adjustment for arsenic exposure and other covariates.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP630117.RAzJoLB1-evP1_ZQs0s_YVY2He9GjFC1fLzBvb8yItPyk130_provenance.
- NP990438.RAhIEjsSnqvGgH5t5cIjsreyXm8pC7TWdPF4AVDmgzGc0130_assertion description "[Carriers of the susceptible MPO and CAT genotypes were at elevated risk (OR 2.1 and 95% CI 0.7-6.2 for MPO; OR 1.9 and 95% CI 0.8-4.7 for CAT) of hyperkeratosis after adjustment for arsenic exposure and other covariates.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP990438.RAhIEjsSnqvGgH5t5cIjsreyXm8pC7TWdPF4AVDmgzGc0130_provenance.
- NP818288.RAOSTJAjb9mQw8-jib6f6l0dz_7gpZfA4SxvX2WOHxDAw130_assertion description "[Carriers of the susceptible MPO and CAT genotypes were at elevated risk (OR 2.1 and 95% CI 0.7-6.2 for MPO; OR 1.9 and 95% CI 0.8-4.7 for CAT) of hyperkeratosis after adjustment for arsenic exposure and other covariates.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP818288.RAOSTJAjb9mQw8-jib6f6l0dz_7gpZfA4SxvX2WOHxDAw130_provenance.
- NP991170.RAPiHA9hq-W98g2ES2GWCOVu7sv_hNRP5br_VO3bWb8ME130_assertion description "[Carriers of the susceptible MPO and CAT genotypes were at elevated risk (OR 2.1 and 95% CI 0.7-6.2 for MPO; OR 1.9 and 95% CI 0.8-4.7 for CAT) of hyperkeratosis after adjustment for arsenic exposure and other covariates.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP991170.RAPiHA9hq-W98g2ES2GWCOVu7sv_hNRP5br_VO3bWb8ME130_provenance.